|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 119.98 USD | -0.40% |
|
-7.47% | -11.90% |
| Apr. 21 | Goldman Sachs Adjusts Price Target on Xylem to $155 From $158, Maintains Buy Rating | MT |
| Apr. 21 | UBS Downgrades Xylem to Neutral From Buy, Adjusts Price Target to $132 From $152 | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 155.18 | +28.82% | 17 | ||||||
| 1,034.83 | +3.85% | 24 | ||||||
| 6,807.5 | +4.68% | 20 | ||||||
| 98.93 | +15.03% | 15 | ||||||
| 232.44 | +4.75% | 21 | ||||||
| 80,813.33 | +13.07% | 15 | ||||||
| 527.75 | -6.63% | 16 | ||||||
| 30.39 | -17.05% | 14 | ||||||
| 112.59 | +8.98% | 20 | ||||||
| 376.44 | -2.69% | 8 | ||||||
| 235.58 | +7.87% | 12 | ||||||
| 62.27 | +2.13% | 15 | ||||||
| 100.84 | -16.71% | 12 | ||||||
| 5,470.91 | +6.62% | 11 | ||||||
| 110 | +21.64% | 19 | ||||||
| 254.35 | +2.73% | 17 | ||||||
| 65.35 | +4.73% | 16 | ||||||
| 89.44 | +19.06% | 14 | ||||||
| Average | 5,365.45 | +5.60% | 16 | ||||||
| Weighted average by Cap. | 5,672.82 | +5.39% | 18 |
- Stock Market
- Equities
- XYL Stock
- Sector Xylem Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
